Forma Therapeutics Holdings Operating Income

Forma Therapeutics Holdings (FMTX) currently reports a operating income of $-190M as of June 2022. That compares with $-150M in the prior-year period — down 30.3% year over year. Use the charts on this page to explore Forma Therapeutics Holdings's operating income history and peer comparisons.

Forma Therapeutics Holdings's operating income decreased from $-150M to $-190M — a 30.3% year-over-year decrease (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Forma Therapeutics Holdings reported $-190M in operating income as of June 2022. That compares with $-150M in the prior-year period — down 30.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-190M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Forma Therapeutics Holdings, and consider following FMTX for alerts when major investors trade the stock.

Forma Therapeutics Holdings is classified in the Healthcare sector. On operating income, it currently shows $-190M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FMTX with unrelated industries.